{
    "id": 33363,
    "fullName": "B2M C45W",
    "impact": "missense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "B2M C45W lies within the Ig-like C1-type domain of the B2m protein (UniProt.org). C45W results in the loss of the disulfide bond between C45 and C100 (PMID: 16648140), increased degradation of B2m, down regulation of HLA class I molecules, and defects in antigen presentation in cultured cells (PMID: 16648140), and therefore, is predicted to result in a loss of B2m protein function.",
            "references": [
                {
                    "id": 1149,
                    "pubMedId": 16648140,
                    "title": "Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16648140"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 567,
        "geneSymbol": "B2M",
        "terms": [
            "B2M",
            "IMD43"
        ]
    },
    "variant": "C45W",
    "createDate": "03/31/2020",
    "updateDate": "03/31/2020",
    "referenceTranscriptCoordinates": {
        "id": 188684,
        "transcript": "NM_004048",
        "gDna": "chr15:g.44715490C>G",
        "cDna": "c.135C>G",
        "protein": "p.C45W",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1406,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a melanoma cell line harboring B2M C45W displayed greatly reduced expression of HLA class I molecules, which was not corrected by treatment with interferon gamma (PMID: 16648140).",
            "molecularProfile": {
                "id": 36050,
                "profileName": "B2M C45W"
            },
            "therapy": {
                "id": 1733,
                "therapyName": "interferon gamma",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 1149,
                    "pubMedId": 16648140,
                    "title": "Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16648140"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 36050,
            "profileName": "B2M C45W",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 188684,
            "transcript": "NM_004048",
            "gDna": "chr15:g.44715490C>G",
            "cDna": "c.135C>G",
            "protein": "p.C45W",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 188685,
            "transcript": "XM_005254549",
            "gDna": "chr15:g.44715490C>G",
            "cDna": "c.135C>G",
            "protein": "p.C45W",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}